269 related articles for article (PubMed ID: 14609817)
1. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
[TBL] [Abstract][Full Text] [Related]
2. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
3. Effects of C-type natriuretic peptide on rat cardiac contractility.
Brusq JM; Mayoux E; Guigui L; Kirilovsky J
Br J Pharmacol; 1999 Sep; 128(1):206-12. PubMed ID: 10498853
[TBL] [Abstract][Full Text] [Related]
4. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
[TBL] [Abstract][Full Text] [Related]
5. Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes.
Zhang Q; Scholz PM; Pilzak A; Su J; Weiss HR
Cell Physiol Biochem; 2007; 20(1-4):157-66. PubMed ID: 17595525
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
7. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
8. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
MacDonell KL; Diamond J
Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
12. SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
Moltzau LR; Aronsen JM; Meier S; Nguyen CH; Hougen K; Ørstavik Ø; Sjaastad I; Christensen G; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Br J Pharmacol; 2013 Sep; 170(2):366-79. PubMed ID: 23808942
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
14. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
[TBL] [Abstract][Full Text] [Related]
15. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
Gorbe A; Giricz Z; Szunyog A; Csont T; Burley DS; Baxter GF; Ferdinandy P
Basic Res Cardiol; 2010 Sep; 105(5):643-50. PubMed ID: 20349314
[TBL] [Abstract][Full Text] [Related]
16. CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors.
Manfra O; Calamera G; Froese A; Arunthavarajah D; Surdo NC; Meier S; Melleby AO; Aasrum M; Aronsen JM; Nikolaev VO; Zaccolo M; Moltzau LR; Levy FO; Andressen KW
Cardiovasc Res; 2022 May; 118(6):1506-1519. PubMed ID: 33970224
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes.
Layland J; Li JM; Shah AM
J Physiol; 2002 Apr; 540(Pt 2):457-67. PubMed ID: 11956336
[TBL] [Abstract][Full Text] [Related]
18. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts.
Su J; Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1367-73. PubMed ID: 15550520
[TBL] [Abstract][Full Text] [Related]
19. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
Ding KH; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
[TBL] [Abstract][Full Text] [Related]
20. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
